Dopamine transporter development in postnatal rat striatum, an autoradiographic study with [3H]WIN 35,428

被引:28
作者
Coulter, CL
Happe, HK
Murrin, LC
机构
[1] Univ Nebraska, Med Ctr, Dept Pharmacol, Omaha, NE 68198 USA
[2] Creighton Univ, Sch Med, Dept Neurol, Omaha, NE 68131 USA
[3] Univ Nebraska, Med Ctr, Dept Internal Med, Neurol Sect, Omaha, NE 68198 USA
来源
DEVELOPMENTAL BRAIN RESEARCH | 1997年 / 104卷 / 1-2期
关键词
dopamine transporter; development; WIN 35,248; cocaine receptor; caudate-putamen; autoradiography;
D O I
10.1016/S0165-3806(97)00135-1
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The dopamine transporter mediates the reinforcing effects of cocaine, thus playing a central role in human cocaine addiction, and perhaps providing the mechanism for inducing the effects of prenatal cocaine exposure. This possibility has stimulated growing interest in the normal and abnormal development of this transporter. [H-3]WIN 35,428 is a cocaine analog that is useful for studying the distribution and density of the dopamine transporter in striatum and other brain regions. The postnatal development of the dopamine transporter in the rat striatum was measured by quantitative autoradiography with [H-3]WIN 35,428. Dopamine transporter levels were low at birth, increased through day 15, followed by much more rapid growth in late postnatal development. The majority of the transporter sites appeared after day 15. Lateral to medial and anterior to posterior gradients in transporter density were established early during development, and there was also an early concentration of transporter in striosomes that became difficult to identify by day 15. Differences between the developmental patterns described here and studies using other ligands for the dopamine transporter suggest there are significant differences in the transporter binding sites for these drugs. These differences in transporter ligand binding characteristics may reflect developmental changes in post-translational modification of the transporter and/or changes in the functional activity rather than simply the presence of the transporter. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 46 条
[1]   ISOPROPYL AND PHENYL-ESTERS OF 3-BETA-(4-SUBSTITUTED PHENYL)TROPAN-2-BETA-CARBOXYLIC ACIDS - POTENT AND SELECTIVE COMPOUNDS FOR THE DOPAMINE TRANSPORTER [J].
CARROLL, FI ;
ABRAHAM, P ;
LEWIN, AH ;
PARHAM, KA ;
BOJA, JW ;
KUHAR, MJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (13) :2497-2500
[2]   THE DOPAMINE TRANSPORTER - IMMUNOCHEMICAL CHARACTERIZATION AND LOCALIZATION IN BRAIN [J].
CILIAX, BJ ;
HEILMAN, C ;
DEMCHYSHYN, LL ;
PRISTUPA, ZB ;
INCE, E ;
HERSCH, SM ;
NIZNIK, HB ;
LEVEY, AI .
JOURNAL OF NEUROSCIENCE, 1995, 15 (03) :1714-1723
[3]  
COOK EH, 1995, AM J HUM GENET, V56, P993
[4]  
Coulter C. L., 1993, Society for Neuroscience Abstracts, V19, P1093
[5]   Postnatal development of the dopamine transporter: A quantitative autoradiographic study [J].
Coulter, CL ;
Happe, HK ;
Murrin, LC .
DEVELOPMENTAL BRAIN RESEARCH, 1996, 92 (02) :172-181
[6]   LOCALIZATION AND QUANTIFICATION OF THE DOPAMINE TRANSPORTER - COMPARISON OF [H-3]WIN-35,428 AND [I-125]RTI-55 [J].
COULTER, CL ;
HAPPE, HK ;
BERGMAN, DA ;
MURRIN, LC .
BRAIN RESEARCH, 1995, 690 (02) :217-224
[7]   ONTOGENESIS OF DOPAMINERGIC-CHOLINERGIC INTERACTIONS IN RAT STRIATUM - NEUROCHEMICAL STUDY [J].
COYLE, JT ;
CAMPOCHIARO, P .
JOURNAL OF NEUROCHEMISTRY, 1976, 27 (03) :673-678
[8]   DOPAMINE TRANSPORTER IMMUNOREACTIVITY IN RAT-BRAIN [J].
FREED, C ;
REVAY, R ;
VAUGHAN, RA ;
KRIEK, E ;
GRANT, S ;
UHL, GR ;
KUHAR, MJ .
JOURNAL OF COMPARATIVE NEUROLOGY, 1995, 359 (02) :340-349
[9]   Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter [J].
Giros, B ;
Jaber, M ;
Jones, SR ;
Wightman, RM ;
Caron, MG .
NATURE, 1996, 379 (6566) :606-612
[10]  
GRACZ LM, 1995, J PHARMACOL EXP THER, V273, P1224